Five Positive Opinions From EU's CHMP Brightens Up The New Year
This article was originally published in The Pink Sheet Daily
Executive Summary
New molecular entities from Valeant/GSK, Eisai, Sanofi and Novartis make the grade for the EU's scientific panel at its January meeting.